Richardson Charles E 4
4 · Icosavax, Inc. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Richardson Charles E
SVP, Technical Operations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-02-14−66,375→ 43,489 totalExercise: $0.84Exp: 2029-09-12→ Common Stock (66,375 underlying) - Exercise/Conversion
Common Stock
2022-02-14$1.04/sh+6,186$6,433→ 167,386 total - Exercise/Conversion
Common Stock
2022-02-14$0.84/sh+66,375$55,755→ 161,200 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-14−6,186→ 16,657 totalExercise: $1.04Exp: 2031-01-28→ Common Stock (6,186 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the option vested on 9/13/2020, and 1/48th of the shares subject to the option vest monthly thereafter.
- [F2]25% of the shares subject to the option vested on 1/29/2022, and 1/48th of the shares subject to the option vest monthly thereafter.